Is Caris Life Sciences, Inc. (CAI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 8.1% / 30% | 1.3% / 30% | 1.7% / 30% | 1.73% / 5% | ✓ HALAL |
| DJIM | 8.1% / 33% | 1.3% / 33% | 1.7% / 33% | 1.73% / 5% | ✓ HALAL |
| MSCI | 123.4% / 33% | 19.2% / 33% | 25.7% / 33% | 1.73% / 5% | ✗ NOT HALAL |
| S&P | 8.1% / 33% | 1.3% / 33% | 1.7% / 33% | 1.73% / 5% | ✓ HALAL |
| FTSE | 123.4% / 33% | 19.2% / 33% | 25.7% / 50% | 1.73% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 66.6% | |
| Operating Margin | 30.2% | |
| Net Margin | -8.4% | |
| Return on Equity (ROE) | -45.4% | |
| Return on Assets (ROA) | 3.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $83M |
| Free Cash Flow | $67M |
| Total Debt | $428M |
| Debt-to-Equity | 74.1 |
| Current Ratio | 7.8 |
| Total Assets | $1.1B |
Price & Trading
| Last Close | $18.33 |
| 50-Day MA | $21.06 |
| 200-Day MA | $27.47 |
| Avg Volume | 2.5M |
|
52-Week Range
$16.43
| |
About Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Purification Calculator
As a halal stock with 1.73% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Caris Life Sciences, Inc. (CAI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Caris Life Sciences, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Caris Life Sciences, Inc.'s debt ratio?
Caris Life Sciences, Inc.'s debt ratio is 8.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 123.4%.
Does Caris Life Sciences, Inc. require dividend purification?
Yes, Caris Life Sciences, Inc. has an impermissible income ratio of 1.73%, which means 1.73% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Caris Life Sciences, Inc.'s key financial metrics?
Caris Life Sciences, Inc. has a market capitalization of $4.8B, and revenue of $812M. The company maintains a gross margin of 66.6% and a net margin of -8.4%. Return on equity stands at -45.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.